Ramelteon is a drug that has been used to treat insomnia for several years. It is a melatonin receptor agonist, meaning that it binds to melatonin receptors in the brain and helps to induce sleep. While the drug has been approved by the FDA for use in adults, it has recently come under scrutiny due to reports of serious side effects. In this article, we will explore the dark side of Ramelteon and investigate its unfortunate side effects.
Ramelteon, also known by the brand name Rozerem, is a non-benzodiazepine hypnotic drug. It is used to help people with insomnia fall asleep and stay asleep. It works by binding to melatonin receptors in the brain, which helps to induce sleep. It is approved by the U.S. Food and Drug Administration (FDA) for use in adults over the age of 18.
Although Ramelteon is generally considered safe for use in adults, it can cause a number of side effects. Common side effects include headache, nausea, dizziness, and drowsiness. Less common side effects include fatigue, dry mouth, constipation, and blurred vision. In addition to these side effects, there have been reports of more serious side effects associated with Ramelteon. These include an increased risk of depression, anxiety, and suicidal thoughts. There have also been reports of an increased risk of liver damage and an increased risk of developing certain types of cancer.
One of the most concerning side effects of Ramelteon is an increased risk of depression. Studies have shown that people who take Ramelteon are more likely to develop depression than those who do not. This risk is especially high in people who have a history of depression or other mental health issues. In addition to an increased risk of depression, there have also been reports of an increased risk of anxiety and suicidal thoughts in people who take Ramelteon. It is important to talk to your doctor if you have any concerns about these side effects.
Another serious side effect of Ramelteon is an increased risk of liver damage. Studies have shown that people who take Ramelteon are more likely to develop liver damage than those who do not. This risk is especially high in people who have a history of liver disease or other liver problems. It is important to talk to your doctor if you have any concerns about this side effect. Your doctor may recommend that you have regular liver function tests to monitor your liver health.
There have also been reports of an increased risk of certain types of cancer in people who take Ramelteon. Studies have shown that people who take Ramelteon are more likely to develop certain types of cancer than those who do not. This risk is especially high in people who have a history of cancer or other health issues. It is important to talk to your doctor if you have any concerns about this side effect. Your doctor may recommend that you have regular cancer screenings to monitor your health.
Ramelteon is a drug that has been used to treat insomnia for several years. While the drug is generally considered safe for use in adults, it can cause a number of side effects. The most concerning side effects are an increased risk of depression, anxiety, suicidal thoughts, liver damage, and certain types of cancer. It is important to talk to your doctor if you have any concerns about these side effects.
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
Dostarlimab Boosts Long-Term Survival in Endometrial Cancer
3.
Germline Profiling May Improve Risk Stratification in t-MNs
4.
Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.
5.
Scientists call into question safety of potential new anticancer treatment
1.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
2.
Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI
3.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
4.
Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance
5.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
Clinical Insights in Hematology
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation